Results 21 to 30 of about 1,385,084 (219)

H-1 Parvovirus as a Cancer-Killing Agent: Past, Present, and Future

open access: yesViruses, 2019
The rat protoparvovirus H-1PV is nonpathogenic in humans, replicates preferentially in cancer cells, and has natural oncolytic and oncosuppressive activities. The virus is able to kill cancer cells by activating several cell death pathways.
Clemens Bretscher, Antonio Marchini
doaj   +1 more source

Immune Conversion of Tumor Microenvironment by Oncolytic Viruses: The Protoparvovirus H-1PV Case Study

open access: yesFrontiers in Immunology, 2019
Cancer cells utilize multiple mechanisms to evade and suppress anticancer immune responses creating a “cold” immunosuppressive tumor microenvironment. Oncolytic virotherapy is emerging as a promising approach to revert tumor immunosuppression and enhance
Antonio Marchini   +6 more
doaj   +1 more source

Oncolytic potency and reduced virus tumor-specificity in oncolytic virotherapy. A mathematical modelling approach. [PDF]

open access: yesPLoS ONE, 2017
In the present paper, we address by means of mathematical modeling the following main question: How can oncolytic virus infection of some normal cells in the vicinity of tumor cells enhance oncolytic virotherapy?
Khaphetsi Joseph Mahasa   +3 more
doaj   +1 more source

Oncolytic Virotherapy for Cancer: Clinical Experience

open access: yesBiomedicines, 2021
Oncolytic viruses are a new class of therapeutics which are largely in the experimental stage, with just one virus approved by the FDA thus far. While the concept of oncolytic virotherapy is not new, advancements in the fields of molecular biology and ...
Shyambabu Chaurasiya   +2 more
doaj   +1 more source

Immune mediated and direct killing of colorectal cancer by reovirus [PDF]

open access: yes, 2012
Colorectal cancer remains the second most prevalent cancer in the world. Novel treatment strategies are necessary, especially for the treatment of metastatic disease.
Adair, Robert Allan
core   +5 more sources

Zika Virus with Increased CpG Dinucleotide Frequencies Shows Oncolytic Activity in Glioblastoma Stem Cells

open access: yesViruses, 2020
We studied whether cytosine phosphate–guanine (CpG) recoding in a viral genome may provide oncolytic candidates with reduced infection kinetics in nonmalignant brain cells, but with high virulence in glioblastoma stem cells (GSCs).
Ivan Trus   +5 more
doaj   +1 more source

Research progress of oncolytic virus combined with PD-1/PD-L1 inhibitors [PDF]

open access: yesJichu yixue yu linchuang, 2022
Oncolytic viruses are often used in combination with immune checkpoint inhibitors represented in two ways by programmed cell death 1/programmed cell death-Ligand 1 (PD-1/PD-L1).
GAN Zi-ying, TANG Hui
doaj   +1 more source

Oncolytic Vaccinia Virus Harboring Aphrocallistes vastus Lectin Inhibits the Growth of Hepatocellular Carcinoma Cells

open access: yesMarine Drugs, 2022
Oncolytic vaccinia virus has been developed as a novel cancer therapeutic drug in recent years. Our previous studies demonstrated that the antitumor effect of oncolytic vaccina virus harboring Aphrocallistes vastus lectin (oncoVV-AVL) was significantly ...
Riqing Jiang   +8 more
doaj   +1 more source

Adenovirus as a Vector and Oncolytic Virus

open access: yesCurrent Issues in Molecular Biology, 2023
Adenoviral vectors, both oncolytic viruses and gene delivery vectors, are among the earliest approved and commercialised vectors for gene therapy. Adenoviruses have high cytotoxicity and immunogenicity. Therefore, lentiviruses or adeno-associated viruses as viral vectors and herpes simplex virus as an oncolytic virus have recently drawn attention. Thus,
Wataru Matsunaga, Akinobu Gotoh
openaire   +3 more sources

The Oncolytic Virus in Cancer Diagnosis and Treatment

open access: yesFrontiers in Oncology, 2020
Cancer has always been an enormous threat to human health and survival. Surgery, radiotherapy, and chemotherapy could improve the survival of cancer patients, but most patients with advanced cancer usually have a poor survival or could not afford the ...
Guo-dong Cao   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy